Clinical trial
Valnoctamide in Mania
NCT00140179 · Beersheva Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00140179 |
|---|---|
| Title | Valnoctamide in Mania |
| Official title | Valnoctamide as a Valproate Substitute With Low Teratogenic Potential: Double-Blind Controlled Clinical Trial |
| Lead sponsor | Beersheva Mental Health Center, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mania, Schizoaffective Disorder, Manic Type |
| Intervention type | Drug |
| Interventions | valnoctamide |
| Enrollment | 80 |
| Start date | Sep 1, 2004 |
| Completion | May 1, 2008 |
| First posted | Sep 1, 2005 |
| Last update posted | Nov 25, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: